Ranolazine extended release - Gilead Sciences
At a glance
- Drug Originator Syntex Pharmaceuticals International
- Drug Licenced by Gilead Sciences; Menarini
- Drug Class Acetanilides; Anti-ischaemics; Antiarrhythmics; Antihyperglycaemics; Ischaemic heart disorder therapies; Piperazines; Small molecules; Vasodilators
- Mechanism of Action Partial fatty acid oxidation inhibitors; Pyruvate dehydrogenase stimulants; Sodium channel antagonists
- USA Patent Applicants MENARINI INTL
- USA Patents 9
- NDAs 1
- Patent Applications 2,267
Table of Contents
Disclaimer